nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Initial insomnia—Varenicline—nicotine dependence	0.0523	0.0523	CcSEcCtD
Methylphenidate—Anger—Varenicline—nicotine dependence	0.0267	0.0267	CcSEcCtD
Methylphenidate—Abnormal behaviour—Varenicline—nicotine dependence	0.0256	0.0256	CcSEcCtD
Methylphenidate—Depressed mood—Varenicline—nicotine dependence	0.0213	0.0213	CcSEcCtD
Methylphenidate—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0195	0.0195	CcSEcCtD
Methylphenidate—Suicide—Varenicline—nicotine dependence	0.0184	0.0184	CcSEcCtD
Methylphenidate—Hostility—Varenicline—nicotine dependence	0.0172	0.0172	CcSEcCtD
Methylphenidate—Suicide attempt—Varenicline—nicotine dependence	0.0168	0.0168	CcSEcCtD
Methylphenidate—Completed suicide—Varenicline—nicotine dependence	0.0162	0.0162	CcSEcCtD
Methylphenidate—Platelet count decreased—Varenicline—nicotine dependence	0.016	0.016	CcSEcCtD
Methylphenidate—Toothache—Varenicline—nicotine dependence	0.0157	0.0157	CcSEcCtD
Methylphenidate—Psoriasis—Varenicline—nicotine dependence	0.0152	0.0152	CcSEcCtD
Methylphenidate—Upset stomach—Varenicline—nicotine dependence	0.0146	0.0146	CcSEcCtD
Methylphenidate—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0141	0.0141	CcSEcCtD
Methylphenidate—Laryngeal pain—Varenicline—nicotine dependence	0.014	0.014	CcSEcCtD
Methylphenidate—Suicidal ideation—Varenicline—nicotine dependence	0.0136	0.0136	CcSEcCtD
Methylphenidate—Mania—Varenicline—nicotine dependence	0.0131	0.0131	CcSEcCtD
Methylphenidate—Fungal infection—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Methylphenidate—Mydriasis—Varenicline—nicotine dependence	0.012	0.012	CcSEcCtD
Methylphenidate—Aggression—Varenicline—nicotine dependence	0.0109	0.0109	CcSEcCtD
Methylphenidate—Chest discomfort—Varenicline—nicotine dependence	0.0108	0.0108	CcSEcCtD
Methylphenidate—Accidental injury—Varenicline—nicotine dependence	0.0108	0.0108	CcSEcCtD
Methylphenidate—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Methylphenidate—Thinking abnormal—Varenicline—nicotine dependence	0.0104	0.0104	CcSEcCtD
Methylphenidate—Blood pressure increased—Varenicline—nicotine dependence	0.00955	0.00955	CcSEcCtD
Methylphenidate—Abnormal dreams—Varenicline—nicotine dependence	0.00943	0.00943	CcSEcCtD
Methylphenidate—Dry eye—Varenicline—nicotine dependence	0.00882	0.00882	CcSEcCtD
Methylphenidate—Mental disability—Varenicline—nicotine dependence	0.00828	0.00828	CcSEcCtD
Methylphenidate—Euphoric mood—Varenicline—nicotine dependence	0.0082	0.0082	CcSEcCtD
Methylphenidate—Lymphadenopathy—Varenicline—nicotine dependence	0.00812	0.00812	CcSEcCtD
Methylphenidate—Sleep disorder—Varenicline—nicotine dependence	0.008	0.008	CcSEcCtD
Methylphenidate—Diabetes mellitus—Varenicline—nicotine dependence	0.00797	0.00797	CcSEcCtD
Methylphenidate—Disorientation—Varenicline—nicotine dependence	0.00775	0.00775	CcSEcCtD
Methylphenidate—Eczema—Varenicline—nicotine dependence	0.00771	0.00771	CcSEcCtD
Methylphenidate—Eye pain—Varenicline—nicotine dependence	0.00767	0.00767	CcSEcCtD
Methylphenidate—Injury—Varenicline—nicotine dependence	0.00754	0.00754	CcSEcCtD
Methylphenidate—Libido decreased—Varenicline—nicotine dependence	0.00747	0.00747	CcSEcCtD
Methylphenidate—Hot flush—Varenicline—nicotine dependence	0.00741	0.00741	CcSEcCtD
Methylphenidate—Increased appetite—Varenicline—nicotine dependence	0.00737	0.00737	CcSEcCtD
Methylphenidate—Menopausal symptoms—Varenicline—nicotine dependence	0.00734	0.00734	CcSEcCtD
Methylphenidate—Visual disturbance—Varenicline—nicotine dependence	0.00731	0.00731	CcSEcCtD
Methylphenidate—Thirst—Varenicline—nicotine dependence	0.00728	0.00728	CcSEcCtD
Methylphenidate—Hypoglycaemia—Varenicline—nicotine dependence	0.0071	0.0071	CcSEcCtD
Methylphenidate—Lethargy—Varenicline—nicotine dependence	0.00707	0.00707	CcSEcCtD
Methylphenidate—Cerebrovascular accident—Varenicline—nicotine dependence	0.00707	0.00707	CcSEcCtD
Methylphenidate—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00687	0.00687	CcSEcCtD
Methylphenidate—Affect lability—Varenicline—nicotine dependence	0.00682	0.00682	CcSEcCtD
Methylphenidate—Migraine—Varenicline—nicotine dependence	0.00682	0.00682	CcSEcCtD
Methylphenidate—Psychotic disorder—Varenicline—nicotine dependence	0.00677	0.00677	CcSEcCtD
Methylphenidate—Irritability—Varenicline—nicotine dependence	0.00661	0.00661	CcSEcCtD
Methylphenidate—Mood swings—Varenicline—nicotine dependence	0.00656	0.00656	CcSEcCtD
Methylphenidate—Liver function test abnormal—Varenicline—nicotine dependence	0.0064	0.0064	CcSEcCtD
Methylphenidate—Abdominal pain upper—Varenicline—nicotine dependence	0.00633	0.00633	CcSEcCtD
Methylphenidate—Breast disorder—Varenicline—nicotine dependence	0.00626	0.00626	CcSEcCtD
Methylphenidate—Cramp muscle—Varenicline—nicotine dependence	0.00624	0.00624	CcSEcCtD
Methylphenidate—Nasopharyngitis—Varenicline—nicotine dependence	0.0062	0.0062	CcSEcCtD
Methylphenidate—Gastritis—Varenicline—nicotine dependence	0.00613	0.00613	CcSEcCtD
Methylphenidate—Asthma—Varenicline—nicotine dependence	0.00599	0.00599	CcSEcCtD
Methylphenidate—Angina pectoris—Varenicline—nicotine dependence	0.00583	0.00583	CcSEcCtD
Methylphenidate—Bronchitis—Varenicline—nicotine dependence	0.00576	0.00576	CcSEcCtD
Methylphenidate—Abdominal discomfort—Varenicline—nicotine dependence	0.00574	0.00574	CcSEcCtD
Methylphenidate—Erectile dysfunction—Varenicline—nicotine dependence	0.00552	0.00552	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Varenicline—nicotine dependence	0.00547	0.00547	CcSEcCtD
Methylphenidate—Weight increased—Varenicline—nicotine dependence	0.00545	0.00545	CcSEcCtD
Methylphenidate—Infestation NOS—Varenicline—nicotine dependence	0.00534	0.00534	CcSEcCtD
Methylphenidate—Infestation—Varenicline—nicotine dependence	0.00534	0.00534	CcSEcCtD
Methylphenidate—Depression—Varenicline—nicotine dependence	0.00532	0.00532	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00529	0.00529	CcSEcCtD
Methylphenidate—Acute coronary syndrome—Varenicline—nicotine dependence	0.00526	0.00526	CcSEcCtD
Methylphenidate—Myocardial infarction—Varenicline—nicotine dependence	0.00523	0.00523	CcSEcCtD
Methylphenidate—Conjunctivitis—Varenicline—nicotine dependence	0.00519	0.00519	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Varenicline—nicotine dependence	0.00505	0.00505	CcSEcCtD
Methylphenidate—Epistaxis—Varenicline—nicotine dependence	0.00504	0.00504	CcSEcCtD
Methylphenidate—Sinusitis—Varenicline—nicotine dependence	0.00501	0.00501	CcSEcCtD
Methylphenidate—Bradycardia—Varenicline—nicotine dependence	0.00488	0.00488	CcSEcCtD
Methylphenidate—Hallucination—Varenicline—nicotine dependence	0.00477	0.00477	CcSEcCtD
Methylphenidate—Urinary tract disorder—Varenicline—nicotine dependence	0.00473	0.00473	CcSEcCtD
Methylphenidate—Connective tissue disorder—Varenicline—nicotine dependence	0.00471	0.00471	CcSEcCtD
Methylphenidate—Urethral disorder—Varenicline—nicotine dependence	0.0047	0.0047	CcSEcCtD
Methylphenidate—Visual impairment—Varenicline—nicotine dependence	0.00462	0.00462	CcSEcCtD
Methylphenidate—Erythema multiforme—Varenicline—nicotine dependence	0.00453	0.00453	CcSEcCtD
Methylphenidate—Eye disorder—Varenicline—nicotine dependence	0.00448	0.00448	CcSEcCtD
Methylphenidate—Cardiac disorder—Varenicline—nicotine dependence	0.00445	0.00445	CcSEcCtD
Methylphenidate—Angiopathy—Varenicline—nicotine dependence	0.00435	0.00435	CcSEcCtD
Methylphenidate—Immune system disorder—Varenicline—nicotine dependence	0.00433	0.00433	CcSEcCtD
Methylphenidate—Mediastinal disorder—Varenicline—nicotine dependence	0.00432	0.00432	CcSEcCtD
Methylphenidate—Chills—Varenicline—nicotine dependence	0.0043	0.0043	CcSEcCtD
Methylphenidate—Arrhythmia—Varenicline—nicotine dependence	0.00428	0.00428	CcSEcCtD
Methylphenidate—Mental disorder—Varenicline—nicotine dependence	0.0042	0.0042	CcSEcCtD
Methylphenidate—Malnutrition—Varenicline—nicotine dependence	0.00417	0.00417	CcSEcCtD
Methylphenidate—Erythema—Varenicline—nicotine dependence	0.00417	0.00417	CcSEcCtD
Methylphenidate—Back pain—Varenicline—nicotine dependence	0.00404	0.00404	CcSEcCtD
Methylphenidate—Muscle spasms—Varenicline—nicotine dependence	0.00401	0.00401	CcSEcCtD
Methylphenidate—Vision blurred—Varenicline—nicotine dependence	0.00393	0.00393	CcSEcCtD
Methylphenidate—Tremor—Varenicline—nicotine dependence	0.00391	0.00391	CcSEcCtD
Methylphenidate—Ill-defined disorder—Varenicline—nicotine dependence	0.00387	0.00387	CcSEcCtD
Methylphenidate—Anaemia—Varenicline—nicotine dependence	0.00386	0.00386	CcSEcCtD
Methylphenidate—Agitation—Varenicline—nicotine dependence	0.00383	0.00383	CcSEcCtD
Methylphenidate—Angioedema—Varenicline—nicotine dependence	0.00381	0.00381	CcSEcCtD
Methylphenidate—Malaise—Varenicline—nicotine dependence	0.00376	0.00376	CcSEcCtD
Methylphenidate—Vertigo—Varenicline—nicotine dependence	0.00375	0.00375	CcSEcCtD
Methylphenidate—Syncope—Varenicline—nicotine dependence	0.00374	0.00374	CcSEcCtD
Methylphenidate—Palpitations—Varenicline—nicotine dependence	0.00369	0.00369	CcSEcCtD
Methylphenidate—Loss of consciousness—Varenicline—nicotine dependence	0.00367	0.00367	CcSEcCtD
Methylphenidate—Cough—Varenicline—nicotine dependence	0.00364	0.00364	CcSEcCtD
Methylphenidate—Convulsion—Varenicline—nicotine dependence	0.00362	0.00362	CcSEcCtD
Methylphenidate—Hypertension—Varenicline—nicotine dependence	0.0036	0.0036	CcSEcCtD
Methylphenidate—Chest pain—Varenicline—nicotine dependence	0.00355	0.00355	CcSEcCtD
Methylphenidate—Arthralgia—Varenicline—nicotine dependence	0.00355	0.00355	CcSEcCtD
Methylphenidate—Myalgia—Varenicline—nicotine dependence	0.00355	0.00355	CcSEcCtD
Methylphenidate—Anxiety—Varenicline—nicotine dependence	0.00354	0.00354	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00353	0.00353	CcSEcCtD
Methylphenidate—Discomfort—Varenicline—nicotine dependence	0.00351	0.00351	CcSEcCtD
Methylphenidate—Dry mouth—Varenicline—nicotine dependence	0.00347	0.00347	CcSEcCtD
Methylphenidate—Oedema—Varenicline—nicotine dependence	0.00341	0.00341	CcSEcCtD
Methylphenidate—Infection—Varenicline—nicotine dependence	0.00338	0.00338	CcSEcCtD
Methylphenidate—Shock—Varenicline—nicotine dependence	0.00335	0.00335	CcSEcCtD
Methylphenidate—Nervous system disorder—Varenicline—nicotine dependence	0.00334	0.00334	CcSEcCtD
Methylphenidate—Thrombocytopenia—Varenicline—nicotine dependence	0.00333	0.00333	CcSEcCtD
Methylphenidate—Tachycardia—Varenicline—nicotine dependence	0.00332	0.00332	CcSEcCtD
Methylphenidate—Skin disorder—Varenicline—nicotine dependence	0.00331	0.00331	CcSEcCtD
Methylphenidate—Hyperhidrosis—Varenicline—nicotine dependence	0.00329	0.00329	CcSEcCtD
Methylphenidate—Anorexia—Varenicline—nicotine dependence	0.00325	0.00325	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0031	0.0031	CcSEcCtD
Methylphenidate—Insomnia—Varenicline—nicotine dependence	0.00308	0.00308	CcSEcCtD
Methylphenidate—Dyspnoea—Varenicline—nicotine dependence	0.00304	0.00304	CcSEcCtD
Methylphenidate—Somnolence—Varenicline—nicotine dependence	0.00303	0.00303	CcSEcCtD
Methylphenidate—Dyspepsia—Varenicline—nicotine dependence	0.003	0.003	CcSEcCtD
Methylphenidate—Decreased appetite—Varenicline—nicotine dependence	0.00296	0.00296	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00294	0.00294	CcSEcCtD
Methylphenidate—Fatigue—Varenicline—nicotine dependence	0.00294	0.00294	CcSEcCtD
Methylphenidate—Constipation—Varenicline—nicotine dependence	0.00291	0.00291	CcSEcCtD
Methylphenidate—Pain—Varenicline—nicotine dependence	0.00291	0.00291	CcSEcCtD
Methylphenidate—Feeling abnormal—Varenicline—nicotine dependence	0.00281	0.00281	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00278	0.00278	CcSEcCtD
Methylphenidate—Urticaria—Varenicline—nicotine dependence	0.00271	0.00271	CcSEcCtD
Methylphenidate—Abdominal pain—Varenicline—nicotine dependence	0.00269	0.00269	CcSEcCtD
Methylphenidate—Body temperature increased—Varenicline—nicotine dependence	0.00269	0.00269	CcSEcCtD
Methylphenidate—Hypersensitivity—Varenicline—nicotine dependence	0.00251	0.00251	CcSEcCtD
Methylphenidate—Asthenia—Varenicline—nicotine dependence	0.00244	0.00244	CcSEcCtD
Methylphenidate—Pruritus—Varenicline—nicotine dependence	0.00241	0.00241	CcSEcCtD
Methylphenidate—Diarrhoea—Varenicline—nicotine dependence	0.00233	0.00233	CcSEcCtD
Methylphenidate—Dizziness—Varenicline—nicotine dependence	0.00225	0.00225	CcSEcCtD
Methylphenidate—Vomiting—Varenicline—nicotine dependence	0.00217	0.00217	CcSEcCtD
Methylphenidate—Rash—Varenicline—nicotine dependence	0.00215	0.00215	CcSEcCtD
Methylphenidate—Dermatitis—Varenicline—nicotine dependence	0.00215	0.00215	CcSEcCtD
Methylphenidate—Headache—Varenicline—nicotine dependence	0.00213	0.00213	CcSEcCtD
Methylphenidate—Nausea—Varenicline—nicotine dependence	0.00202	0.00202	CcSEcCtD
